Trinomab
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $178M
Investors
- 11
About Trinomab
Established in 2015 and based in Zhuhai, China, Trinomab is a biopharmaceutical company engaged in the R&D of novel fully native human monoclonal antibody (mAb) drugs. The Chairman and CTO, Huaxin Liao, graduated from Shanghai Medical University., Ltd. In November 2022, TNM002 entered Phase III clinical trial. The company is developing multiple product pipelines. Those new drugs will be used for prevention of respiratory syncytial virus (RSV) infection, prevention of tetanus, herpes zoster virus, hCMV infection, arthralgia, bacterial infectious shock, and rabies prevention. Those drugs' development is based on the self-developed human monoclonal antibodies (Hitmab) platform.
Who invested in Trinomab
11 investors across 2 rounds
See all investors in Trinomab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Trinomab
Who invested in Trinomab?
Trinomab has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trinomab raised?
Trinomab has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Trinomab last raise money?
Trinomab's most recent round on record is a Series A, in Aug 2021.
What does Trinomab do?
Established in 2015 and based in Zhuhai, China, Trinomab is a biopharmaceutical company engaged in the R&D of novel fully native human monoclonal antibody (mAb) drugs.
Where is Trinomab headquartered?
Trinomab is headquartered in Zhuhai, China.
Which VCs invest in companies like Trinomab?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Trinomab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Trinomab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.